Results of the EMERGENT-3 trial confirm that the novel investigational antipsychotic xanomeline-trospium (KarXT, Karuna Therapeutics) is effective and well tolerated in adults with schizophrenia experiencing acute […]

Clinicians are reporting what is believed to be the first documented case of toxic leukoencephalopathy (TLE) caused by inhaling fentanyl. “While heroin has been the principal […]

Magnetic seizure therapy (MST) offers similar efficacy as electroconvulsive therapy (ECT) in treating bipolar mania in adults, with significantly fewer adverse effects on language abilities, new […]

Adolescents are routinely exposed to promotional content for e-cigarettes and vaping products on Instagram, which is in violation of regulatory policies. In a study, researchers found […]

By age 12 years, more than 14% of children have tried alcohol or tobacco, and religion, race, and income are the top predictors beginning to use […]

A single oral administration of MM120 (lysergide d-tartrate), an investigational lysergic acid diethylamide (LSD)–based medicine being developed by Mind Medicine Inc (MindMed), provided rapid and durable […]

High olive oil consumption is associated with a significant decreased risk for dementia-related mortality, regardless of overall diet quality, a new study suggested. Data from a […]

A novel training program that uses theater and improv can help empower Asian American, Native Hawaiian, and Pacific Islander (AANHPI) medical students faced with racial bias […]

About 85% of patients with opioid use disorder (OUD) are described in clinical notes as being abusers, addicts, junkies, or with other stigmatizing terms, preliminary results […]